Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression

Joint Authors

Muñóz-Godínez, Ricardo
de Lourdes Mora-García, María
Weiss-Steider, Benny
Montesinos-Montesinos, Juan José
del Carmen Aguilar-Lemarroy, Adriana
García-Rocha, Rosario
Hernández-Montes, Jorge
Azucena Don-López, Christian
Ávila-Ibarra, Luis Roberto
Torres-Pineda, Daniela Berenice
Molina-Castillo, Gabriela
Chacón-Salinas, Rommel
Vallejo-Castillo, Luis
Pérez-Tapia, Sonia Mayra
Monroy-García, Alberto

Source

Mediators of Inflammation

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-14, 14 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-12-07

Country of Publication

Egypt

No. of Pages

14

Main Subjects

Diseases

Abstract EN

Persistent infection with high-risk human papillomavirus (HR-HPV) is the main factor in the development of cervical cancer (CC).

The presence of immunosuppressive factors plays an important role in the development of this type of cancer.

To determine whether CD39 and CD73, which participate in the production of immunosuppressive adenosine (Ado), are involved in the progression of CC, we compared the concentrations and hydrolytic activity of these ectonucleotidases in platelet-free plasma (PFP) samples between patients with low-grade squamous intraepithelial lesions (LSILs) (n=18), high-grade squamous intraepithelial lesions (HSILs) (n=12), and CC (n=19) and normal donors (NDs) (n=15).

The concentrations of CD39 and CD73 in PFP increased with disease progression (r=0.5929, p<0.001).

The PFP of patients with HSILs or CC showed the highest concentrations of CD39 (2.3 and 2.2 times that of the NDs, respectively) and CD73 (1.7 and 2.68 times that of the NDs, respectively), which were associated with a high capacity to generate Ado from the hydrolysis of adenosine diphosphate (ADP) and adenosine monophosphate (AMP).

The addition of POM-1 and APCP, specific inhibitors of CD39 and CD73, respectively, inhibited the ADPase and AMPase activity of PFP by more than 90%.

A high level of the 90 kD isoform of CD73 was detected in the PFP of patients with HSILs or CC.

Digestion with endoglycosidase H and N-glycanase generated CD73 with weights of approximately 90 kD, 85 kD, 80 kD, and 70 kD.

In addition, the levels of transforming grow factor-β (TGF-β) in the PFPs of patients with LSIL, HSIL and CC positively correlated with those of CD39 (r=0.4432, p<0.001) and CD73 (r=0.5786, p<0.001).

These results suggest that persistent infection by HR-HPV and the concomitant production of TGF-β promote the expression of CD39 and CD73 to favor CC progression through Ado generation.

American Psychological Association (APA)

Muñóz-Godínez, Ricardo& de Lourdes Mora-García, María& Weiss-Steider, Benny& Montesinos-Montesinos, Juan José& del Carmen Aguilar-Lemarroy, Adriana& García-Rocha, Rosario…[et al.]. 2020. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression. Mediators of Inflammation،Vol. 2020, no. 2020, pp.1-14.
https://search.emarefa.net/detail/BIM-1191516

Modern Language Association (MLA)

Muñóz-Godínez, Ricardo…[et al.]. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression. Mediators of Inflammation No. 2020 (2020), pp.1-14.
https://search.emarefa.net/detail/BIM-1191516

American Medical Association (AMA)

Muñóz-Godínez, Ricardo& de Lourdes Mora-García, María& Weiss-Steider, Benny& Montesinos-Montesinos, Juan José& del Carmen Aguilar-Lemarroy, Adriana& García-Rocha, Rosario…[et al.]. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression. Mediators of Inflammation. 2020. Vol. 2020, no. 2020, pp.1-14.
https://search.emarefa.net/detail/BIM-1191516

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1191516